Isolation of lagarocladone A demonstrates hepatoprotective effects against cytotoxicity in liver cells, suggesting therapeutic potential.
Lagarocladone A (1), a novel polycyclic polyprenylated acylphloroglucinol (PPAP) with a highly rearranged skeleton, along with a new spiro-PPAP, lagarocladone B (2), and three known analogues (3-5), were isolated from the aerial parts of Hypericum lagarocladum. Compound 1 possesses an unprecedented 6/6/5/5/6/5 ring system featuring a spiro[2-oxa-bicyclo[4.3.0]nonane-4,6'-tetracyclo[10.4.0.0³,¹⁰.0⁴,⁸]hexadecane] core. Their structures were elucidated by comprehensive spectroscopic data analysis, CASE algorithms, quantum ¹³C NMR DP4+, and electronic circular dichroism calculations. Significantly, compound 1 exhibited hepatoprotective activity against APAP-induced cytotoxicity in HepG2 cells, potentially through attenuating oxidative stress and preserving membrane integrity.
No takes yet. Share an insight, caveat, or question.
Lai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: